9.835USD-0.35%Mkt Cap: 342.07M USDP/E: —Last update: 2026-06-01
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cispl…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap342.07M USD
Enterprise Value304.76M USD
Revenue (TTM)51.00M USD
Gross Profit40.88M USD
Net Income (TTM)-9.74M USD
Revenue/Share1.685 USD
Last Price9.835 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees35
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINCA31447P1009
Valuation
P/E (Trailing)—
P/E (Forward)9.67
PEG1.47
EV/EBITDA-55.51
EV/Revenue5.98
P/S6.76
P/B9.10
EPS (TTM)-0.29
EPS (Forward)1.03
52W Range
5.65087% of range10.45
52W High10.45 USD
52W Low5.650 USD
Profitability
Gross Margin91.57%
Oper. Margin-0.79%
EBITDA Margin-10.77%
Profit Margin-21.82%
ROE-27.46%
ROA-13.81%
Growth
Revenue Growth72.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.47M USD
CapEx (TTM)—
FCF Margin-4.65%
FCF Yield-0.69%
Net Debt-40.18M USD
Net Debt/EBITDA7.32
Balance Sheet
Debt/Equity0.00
Current Ratio6.98
Quick Ratio6.15
Book Value/Sh1.091 USD
Cash/Share1.157 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)15.57 USD
Target Range13.00 USD – 18.00 USD
# Analysts7
Ownership
Shares Out.34.74M
Float16.88M
Insiders14.39%
Institutions54.29%
Short Interest
Short Ratio2.5d
Short % Float2.08%
Short % Out.1.79%
Shares Short623.38K
Short (prev mo.)930.61K
Technical
SMA 507.236 (+35.9%)
SMA 2007.993 (+23.0%)
Beta0.91
S&P 52W Chg27.94%
Avg Vol (30d)268.82K
Avg Vol (10d)568.59K
Technical Indicators
RSI (14)71.9
MACD0.8690
MACD Signal0.7435
MACD Hist.+0.1255
BB Upper11.51 USD
BB Middle8.483 USD
BB Lower5.456 USD
BB Width71.37%
ATR (14)0.5298 USD
Vol Ratio (20d)0.83x